Ann Myers Turpen

Title: **Ann Myers Turpen: A Pioneer in Recombinant Viral Nucleic Acids**

Introduction

Ann Myers Turpen, a distinguished inventor based in Vacaville, California, has made significant contributions to the field of biotechnology through her innovative inventions. With a remarkable portfolio of eight patents, she has focused on developing recombinant viral nucleic acids that have potential applications in various host organisms, including plants and animals.

Latest Patents

Among her latest inventions, Turpen has developed groundbreaking patents relating to recombinant viral nucleic acids. These inventions involve a recombinant viral nucleic acid derived from a (+) sense, single-stranded RNA virus, which encodes several critical components, including a native subgenomic promoter and nucleic acid sequences for viral coat proteins. Notably, her work ensures that the first and second viral subgenomic promoters are not homologous, enhancing the efficiency of transcription in host organisms. The recombinant viral nucleic acid has proven advantageous as it can systemically transcribe additional nucleic acids in diverse hosts, offering promising prospects for agricultural and medical applications.

Career Highlights

Turpen has built an impressive career, working with prominent companies such as Biosource Technologies, Inc. and Large Scale Biology Corporation. Her expertise in recombinant viral technology has cemented her reputation as a leading inventor in the biotechnology sector. Through her patents, she has played a crucial role in advancing the understanding and utility of viral vectors in gene therapy and other innovative research applications.

Collaborations

Throughout her career, Turpen has collaborated with notable coworkers including William O. Dawson and Thomas H. Turpen. Their teamwork has led to significant advancements in viral research and development, further enhancing the capabilities and applications of recombinant viral nucleic acids. These collaborations illustrate the power of partnership in driving innovation within the scientific community.

Conclusion

Ann Myers Turpen's contributions to the field of biotechnology through her patents on recombinant viral nucleic acids represent a substantial step forward in the development of viral-based technologies. Her work not only showcases her innovative spirit but also underscores the importance of collaboration in achieving remarkable scientific breakthroughs. As her patents continue to facilitate advancements in various applications, Turpen's legacy as a pioneer in her field remains poised to inspire future generations of inventors.